Both total and phosphorylated tau are increased in Alzheimer's disease

Sjögren, M.; Davidsson, P.; Tullberg, M.; Minthon, L.; Wallin, A.; Wikkelso, C.; Granérus, A.-K.; Vanderstichele, H.; Vanmechelen, E.; Blennow, K.
May 2001
Journal of Neurology, Neurosurgery & Psychiatry;May2001, p624
Academic Journal
No abstract available.


Related Articles

  • Tau-based Therapies for Alzheimer's Disease: Wave of the Future? Desai, Abhilash K.; Chand, Pratap // Primary Psychiatry;Jul2009, Vol. 16 Issue 7, p40 

    The development of effective neuroprotective agents for sporadic Alzheimer's disease is a formidable challenge because this disease is multifacterial and heterogeneous. Tau-mediated neurotoxicity has been implicated as a downstream effector of Abeta pathology and as an increasingly compelling...

  • Microtubule-associated protein tau is a substrate of ATP/Mg2+-dependent proteasome protease system. Zhang, J. Y.; Liu, S. J.; Li, H. L.; Wang, J.-Z. // Journal of Neural Transmission;Apr2005, Vol. 112 Issue 4, p547 

    Deposition of hyperphosphorylated microtubule-associated protein tau is a recognized pathological process in Alzheimer’s disease (AD) brain, however, the mechanism leading to tau accumulation is still not understood. In the present study, we found that different forms of tau, including...

  • Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimers disease. Liu, Fei; Shi, Jianhua; Tanimukai, Hitoshi; Gu, Jinhua; Gu, Jianlan; Grundke-Iqbal, Inge; Iqbal, Khalid; Gong, Cheng-Xin // Brain: A Journal of Neurology;Jul2009, Vol. 132 Issue 7, p1820 

    It has been established for a long time that brain glucose metabolism is impaired in Alzheimers disease. Recent studies have demonstrated that impaired brain glucose metabolism precedes the appearance of clinical symptoms, implying its active role in the development of Alzheimers disease....

  • The Role of Tau Phosphorylation in the Pathogenesis of Alzheimer's Disease. Kaihong Mi; Johnson, Gail V. W. // Current Alzheimer Research;Dec2006, Vol. 3 Issue 5, p449 

    The microtubule-associated protein tau, which is abundantly expressed in neurons, is deposited in cells in an abnormally phosphorylated state as fibrillar lesions in numerous neurodegenerative diseases, with the most notable being Alzheimer's disease. Tau plays a crucial role in the neuron as it...

  • Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Irwin, David J.; Cohen, Todd J.; Grossman, Murray; Arnold, Steven E.; Xie, Sharon X.; Lee, Virginia M.-Y.; Trojanowski, John Q. // Brain: A Journal of Neurology;Mar2012, Vol. 135 Issue 3, p807 

    The microtubule-binding protein, tau, is the major component of neurofibrillary inclusions characteristic of Alzheimer's disease and related neurodegenerative tauopathies. When tau fibrillizes, it undergoes abnormal post-translational modifications resulting in decreased solubility and altered...

  • Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus. Yoshida, S.; Maeda, M.; Kaku, S.; Ikeya, H.; Yamada, K.; Nakaike, S. // Journal of Neural Transmission;Nov2006, Vol. 113 Issue 11, p1803 

    It has been pointed out that hyperphosphorylation of microtubule-associated protein tau caused by stress might participate in the early stages of Alzheimer’s disease pathogenesis. In the present study, we investigated the effects of cold water stress (CWS) on tau phosphorylation in the...

  • Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin Deficiency. Clodfelder-Miller, Buffie J.; Zmijewska, Anna A.; Johnson, Gaff V. W.; Jope, Richard S. // Diabetes;Dec2006, Vol. 55 Issue 12, p3320 

    Deficient signaling by insulin, as occurs in diabetes, is associated with impaired brain function, and diabetes is associated with an increased prevalence of Alzheimer's disease. One of the hallmark pathological characteristics of Alzheimer's disease is the presence of neurofibrillary tangles...

  • The Cellular Distribution and Ser262 Phosphorylation of Tau Protein Are Regulated by BDNF In Vitro. Chen, Qian; Zhou, Zhou; Zhang, Lei; Xu, Shangcheng; Chen, Chunhai; Yu, Zhengping // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    The brain-enriched microtubule-associated protein tau, a critical regulator of cytoskeletal dynamics, forms insoluble aggregates in a number of neurodegenerative diseases termed tauopathies, including Alzheimer's disease (AD). Hyperphosphorylation of tau protein is an important mechanism for...

  • Hrd1 Facilitates Tau Degradation and Promotes Neuron Survival. Shen, Y. X.; Sun, A. M.; Fang, S.; Feng, L. J.; Li, Q.; Hou, H. L.; Liu, C.; Wang, H. P.; Shen, J. L.; Luo, J.; Zhou, J. N. // Current Molecular Medicine;Feb2012, Vol. 12 Issue 2, p138 

    Intraneuronal accumulation of abnormal phosphorylated tau (p-tau) is a molecular pathology in many neurodegenerative tauopathies, including Alzheimer's disease (AD) and frontotemporal dementia with parkinsonism-linked to chromosome 17 (FTDP-17). However, the underlying mechanism remains unclear....

  • The Physiological Link between Metabolic Rate Depression and Tau Phosphorylation in Mammalian Hibernation. Stieler, Jens T.; Bullmann, Torsten; Kohl, Franziska; Tøien, Øivind; Brückner, Martina K.; Härtig, Wolfgang; Barnes, Brian M.; Arendt, Thomas // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Abnormal phosphorylation and aggregation of tau protein are hallmarks of a variety of neurological disorders, including Alzheimer's disease (AD). Increased tau phosphorylation is assumed to represent an early event in pathogenesis and a pivotal aspect for aggregation and formation of...


Read the Article


Sign out of this library

Other Topics